Stock Analysis

Charm Care Second Quarter 2025 Earnings: EPS: JP¥19.59 (vs JP¥20.70 in 2Q 2024)

TSE:6062
Source: Shutterstock

Charm Care (TSE:6062) Second Quarter 2025 Results

Key Financial Results

  • Revenue: JP¥10.2b (up 19% from 2Q 2024).
  • Net income: JP¥640.0m (down 5.3% from 2Q 2024).
  • Profit margin: 6.3% (down from 7.9% in 2Q 2024). The decrease in margin was driven by higher expenses.
  • EPS: JP¥19.59 (down from JP¥20.70 in 2Q 2024).
earnings-and-revenue-growth
TSE:6062 Earnings and Revenue Growth February 7th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Charm Care Earnings Insights

Looking ahead, revenue is forecast to grow 8.1% p.a. on average during the next 3 years, compared to a 4.7% growth forecast for the Healthcare industry in Japan.

Performance of the Japanese Healthcare industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on Charm Care's balance sheet.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About TSE:6062

Charm Care

Engages in nursing care business.

Undervalued with solid track record.

Community Narratives

Priced for AI perfection - cracks are emerging
Fair Value US$90.15|44.027% overvalued
ChadWisperer
ChadWisperer
Community Contributor
NVDA Market Outlook
Fair Value US$341.12|61.937% undervalued
NateF
NateF
Community Contributor
Karoon Energy (ASX:KAR) - Buy Baby Buy 🚀
Fair Value AU$5.10|70.294% undervalued
StockMan
StockMan
Community Contributor